WILMINGTON, Delaware, Sept. 27 (TNSres) -- AstraZeneca, a biopharmaceutical company, issued the following news release: * * * Based on LAURA Phase III trial results which showed TAGRISSO extended median progression-free survival by more than three years * * * AstraZeneca's TAGRISSO (osimertinib)​ has been approved in the US for the treatment of adult patients with unresectable, Stage III epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) whose disease has   more

BOSTON, Massachusetts, Sept. 27 -- The U.S. Department of Justice Drug Enforcement Administration's New England Division issued the following news release: STAMFORD, Conn. Vanessa Roberts Avery, United States Attorney for the District of Connecticut, announced that DELROY ANDERSON, also known as "Max," 57, formerly of Stamford, was sentenced today by U.S. District Judge Kari A. Dooley in Bridgeport to 13 months of imprisonment, followed by three years of supervised release, for leading a money   more

BOSTON, Massachusetts, Sept. 28 -- The office of the U.S. Attorney for the District of Massachusetts issued the following news release: Three alleged members of La Mara Salvatrucha, or MS-13, have been charged for their alleged roles in two separate murders in Massachusetts in December 2010 and July 2020. William Pineda Portillo, a/k/a "Humilde," 31, of Everett, and Jose Vasquez, a/k/a "Cholo," a/k/a "Little Crazy, 31, of Somerville, are charged in a second superseding indictment with one coun  more

PARIS, France, Sept. 28 (TNSres) -- Sanofi, a life sciences company, issued the following news release: * * * Dupixent approved in China as the first-ever biologic medicine for patients with COPD * Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark phase 3 studies showing Dupixent significantly reduced exacerbations, improved lung function, and also improved health-related quality of life * COPD is the most prevalent chro  more